EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BioAdaptives's Enterprise Value is $0.76 Mil.
BioAdaptives's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.22 Mil. Therefore, BioAdaptives's EV-to-FCF for today is -3.39.
The historical rank and industry rank for BioAdaptives's EV-to-FCF or its related term are showing as below:
BDPT'
s EV-to-FCF Range Over the Past 10 Years
Min: -3.39 Med: 128.39 Max: 707.5
Current: -3.39
During the past 9 years, the highest EV-to-FCF of BioAdaptives was 707.50. The lowest was -3.39. And the median was 128.39.
BDPT's EV-to-FCF is ranked worse than 100% of 1153
companies
in the Consumer Packaged Goods industry
Industry Median: 18.19
vs BDPT: -3.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for BioAdaptives's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioAdaptives's EV-to-FCF
For the Packaged Foods subindustry, BioAdaptives's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioAdaptives's EV-to-FCF Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where BioAdaptives's EV-to-FCF falls into.
BioAdaptives EV-to-FCF Calculation
BioAdaptives's EV-to-FCF for today is calculated as:
BioAdaptives's current Enterprise Value is $0.76 Mil.
BioAdaptives's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioAdaptives (OTCPK:BDPT) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
BioAdaptives's PE Ratio for today is calculated as:
BioAdaptives's share price for today is $0.0004.
BioAdaptives's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
BioAdaptives EV-to-FCF Related Terms
Thank you for viewing the detailed overview of BioAdaptives's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BDPT has been successfully added to your 